STING Restricts Oncolytic HSV Replication and Spread in Resistant Malignant Peripheral Nerve Sheath Tumors but Is Dispensable for Basal Interferon Stimulated Gene Upregulation.

Molecular Therapy - Oncolytics - United Kingdom
doi 10.1016/j.omto.2019.09.001
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Somatic Mutations of SUZ12 in Malignant Peripheral Nerve Sheath Tumors

Nature Genetics
Genetics
2014English

Tp53 Mutant Zebrafish Develop Malignant Peripheral Nerve Sheath Tumors

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2005English

Survivin Is a Viable Target for the Treatment of Malignant Peripheral Nerve Sheath Tumors

Clinical Cancer Research
Cancer ResearchOncology
2012English

MicroRNA Gene Regulatory Networks in Peripheral Nerve Sheath Tumors

2012English

A Clinicopathological and Immunohistochemical Study of Malignant Peripheral Nerve Sheath Tumors

International Journal of Research in Medical Sciences
2014English

Malignant Peripheral Nerve Sheath Tumors (MPNST) in the Head and Neck Region

2018English

Feline Peripheral Nerve Sheath Tumors

Veterinary Pathology
Veterinary
2009English

PRC2 Is Recurrently Inactivated Through EED or SUZ12 Loss in Malignant Peripheral Nerve Sheath Tumors

Nature Genetics
Genetics
2014English

STAT1 and NF- B Inhibitors Diminish Basal Interferon-Stimulated Gene Expression and Improve the Productive Infection of Oncolytic HSV in MPNST Cells

Molecular Cancer Research
Cancer ResearchOncologyMolecular Biology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy